Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1371 Other hematologic neoplasm 418 Myeloid 34 Plasma cell 29 Sarcoma 27 Dermatologic 15 CNS 12 Classical hematology 9 Tumor-Agnostic 4 Thoracic 4 Breast 4 Head & Neck 3 Genitourinary 3 Other solid neoplasm 2 Gynecologic 2 Gastrointestinal 2 Other neoplasm 1 Other 1

Conditions

Mucositis 1 Leukemia 1

Interventions

Exercise 27 Metformin 24 Methods 14 Radiotherapy 13 Early Intervention, Educational 13 Educational Status 12 Counseling 12 Surveys and Questionnaires 10 Standard of Care 10 Nutrition Assessment 9 Resistance Training 8 Diet Therapy 8 Cisplatin 8 naloxegol 7 Tirzepatide 7 Diet 7 alvimopan 6 Psychiatric Rehabilitation 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 Radiation 5 Low-Level Light Therapy 5 Liraglutide 5 Injections 5 Exenatide 5 Dexamethasone 5 Cryotherapy 5 semaglutide 4 angiotensin I (1-7) 4 Vitamin D 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Rituximab × Other × Clear all

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡